Opens in a new tab

Juul Labs International v NJOY Netherlands (CoA, UPC_CoA_5/2025, 9 January 2026)

Date9 January 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionWithdrawal (RoP265)
Case number(s)UPC_CoA_5/2025
Registry referenceUPC_CoA_5/2025 · APL_289/2025
PartiesJuul Labs International, Inc. v. NJOY Netherlands B.V.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

The Court of Appeal allows Juul Labs International, Inc. to withdraw its appeal (UPC_CoA_5/2025) against the decision of the Paris Central Division of 5 November 2024 (UPC_CFI_309/2023), which had revoked EP 3 498 115 at the request of NJOY Netherlands B.V. for twelve Contracting Member States. In the meantime, the EPO Boards of Appeal had upheld the revocation of the patent on 17 October 2025. The Court orders Juul Labs to bear the costs of the appeal and refunds 60% of the appeal court fees. On the same day it ruled to the same effect, in separate decisions, on appeals UPC_CoA_237/2025 and UPC_CoA_328/2025 between the same parties. The Court declines to shift costs onto a revocation claimant who did not wait for the outcome of the opposition.

Question

May an appellant withdrawing after the EPO has finally revoked the patent have the costs of the appeal borne by the respondent, on the ground that the revocation action was unnecessary while the opposition was pending?

Decision

The conditions of Rule 265.1 RoP apply to the withdrawal of an appeal. Since NJOY consented, it has no legitimate interest in a decision and the withdrawal is permitted (paragraphs 7 to 10). As the application was lodged before 31 December 2025, former Rule 370.9(b)(i) RoP applies: 60% of the appeal fees are refunded (paragraph 11). A withdrawing appellant is, as a rule, the unsuccessful party (paragraph 14). The exception to Art. 69(1) UPCA, recognised where the proprietor immediately surrenders the patent and requests revocation under Art. 105a EPC within the time limit for the defence, does not apply because Juul Labs defended its patent at first instance (paragraphs 15 to 17).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 69(1)
Rules of Procedure
Rules 151, 265.1, 360 and 370.9
European Patent Convention
Art. 105a
Case law cited
10x Genomics v Curio Bioscience, Court of Appeal, 5 July 2024, UPC_CoA_234/2024, Avago v Tesla, Court of Appeal, 15 January 2025, UPC_CoA_637/2024, 638/2024 and 639/2024, Avago Technologies International Sales v Tesla Germany and Tesla Manufacturing Brandenburg, Court of Appeal, 15 January 2025, UPC_CoA_629/2024, 631/2024 and 632/2024, Stäubli Tec, Court of Appeal, 26 March 2025, UPC_CoA_290/2024.

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CoA_5/2025 official number

Follow this case

First instance cited in the decision: UPC_CFI_309/2023

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Withdrawal (RoP265)
Outcome (Dhenne Avocats summary)
Le désistement d’appel est autorisé avec l’accord de l’intimée. L’appelant supporte les frais de l’appel malgré la révocation du brevet par l’OEB et obtient le remboursement de 60 % des taxes d’appel.
Appeal
Decision of the Court of Appeal (first instance cited: UPC_CFI_309/2023).
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 498 115Mentioned in the analysis (role not qualified)
Also mentioned in 5 other decision(s): NJOY Netherlands v Juul Labs (CFI, ORD_598482/2023, 5 November 2024) · NJOY Netherlands v Juul Labs International (CFI, 9 June 2025) · Juul Labs v NJOY Netherlands (CoA, 30 April 2025) · Nicoventures Trading v Juul Labs (CoA, ORD_13786/2025, 25 April 2025) · NJOY Netherlands v Juul Labs International (CFI, 17 January 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.